[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@TreviThera](/creator/twitter/TreviThera) "Backed by positive clinical results our investigational therapy Haduvio has the potential to redefine what is possible in chronic cough treatment. #ControllingCoughWhereItCounts" [X Link](https://x.com/TreviThera/status/1981443682952794395) [@TreviThera](/creator/x/TreviThera) 2025-10-23T19:32Z XXX followers, XX engagements "Trevi is proud to be presenting at CHEST 2025 We are excited to share our clinical advancements of nalbuphine ER our investigational treatment for chronic cough. Read the full PR here: #CHEST2025 #ChronicCough @accpchest" [X Link](https://x.com/TreviThera/status/1975908198805622800) [@TreviThera](/creator/x/TreviThera) 2025-10-08T12:56Z XXX followers, XXX engagements "Trevi is proud to share Associate Professor Imran Satia's interview discussing our Phase 2a RIVER trial of nalbuphine ER in patients with refractory chronic cough. Watch the full interview here: #ControllingCoughWhereItCounts #RefractoryChronicCough" [X Link](https://x.com/TreviThera/status/1981781761961906418) [@TreviThera](/creator/x/TreviThera) 2025-10-24T17:56Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@TreviThera
"Backed by positive clinical results our investigational therapy Haduvio has the potential to redefine what is possible in chronic cough treatment. #ControllingCoughWhereItCounts"
X Link @TreviThera 2025-10-23T19:32Z XXX followers, XX engagements
"Trevi is proud to be presenting at CHEST 2025 We are excited to share our clinical advancements of nalbuphine ER our investigational treatment for chronic cough. Read the full PR here: #CHEST2025 #ChronicCough @accpchest"
X Link @TreviThera 2025-10-08T12:56Z XXX followers, XXX engagements
"Trevi is proud to share Associate Professor Imran Satia's interview discussing our Phase 2a RIVER trial of nalbuphine ER in patients with refractory chronic cough. Watch the full interview here: #ControllingCoughWhereItCounts #RefractoryChronicCough"
X Link @TreviThera 2025-10-24T17:56Z XXX followers, XX engagements
/creator/twitter::356229474/posts